These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Magnesium-deficiency does not alter calcineurin inhibitors activity in mice. Hulin A; Lamrani L; Sabbagh F; Tallet A; Lecerf F; Bac P; German-Fattal M Transpl Immunol; 2012 Jan; 26(1):55-61. PubMed ID: 21964379 [TBL] [Abstract][Full Text] [Related]
6. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Doesch AO; Mueller S; Konstandin M; Celik S; Erbel C; Kristen A; Frankenstein L; Koch A; Dengler TJ; Ehlermann P; Zugck C; De Geest S; Katus HA Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673 [TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies. Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386 [TBL] [Abstract][Full Text] [Related]
8. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors. Prasad GV; Nash MM; McFarlane PA; Zaltzman JS Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328 [TBL] [Abstract][Full Text] [Related]
9. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors. Coates PT; Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286 [No Abstract] [Full Text] [Related]
10. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells. Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815 [TBL] [Abstract][Full Text] [Related]
12. Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome. Afzali B; Goldsmith DJ Clin Nephrol; 2003 Mar; 59(3):225-8. PubMed ID: 12653269 [TBL] [Abstract][Full Text] [Related]
13. The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors. Grimer M; Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S98-S105. PubMed ID: 17316288 [No Abstract] [Full Text] [Related]
14. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Neuberger J; Gunson B; Hubscher S; Nightingale P Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790 [TBL] [Abstract][Full Text] [Related]
15. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients. Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573 [TBL] [Abstract][Full Text] [Related]
16. The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects. Jose M; Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S66-74. PubMed ID: 17316284 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
18. Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors. Bai JP; Lesko LJ; Burckart GJ Pharmacotherapy; 2010 Feb; 30(2):195-209. PubMed ID: 20099993 [TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms. Ferrari U; Empl M; Kim KS; Sostak P; Förderreuther S; Straube A Headache; 2005 Mar; 45(3):211-4. PubMed ID: 15836594 [TBL] [Abstract][Full Text] [Related]
20. [Topical calcineurin inhibitors in atopic eczema -- contra]. Abeck D Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1615. PubMed ID: 16823714 [No Abstract] [Full Text] [Related] [Next] [New Search]